ARIAD Pharmaceuticals (ARIA) Misses Q2 EPS by 1c, Comments on Outlook
Tweet Send to a Friend
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) reports a Q2 loss of $0.25, 1 cent worse than estimates. Revenues were $189K ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
